Ethical Considerations in Harm Reduction Strategies for Diabetes

This report examines the ethical considerations essential for implementing harm reduction strategies in diabetes management, specifically within Aboriginal or Indigenous communities. It emphasizes the importance of ethical approvals from review committees and the necessity of obtaining informed consent from participants, ensuring their voluntary participation and respecting their privacy. The report highlights the significance of maintaining the confidentiality of patient data, securing it through locked cabinets or protected databases, and using coded or numbered participant identifiers to protect their identities. Furthermore, the report stresses the need for cultural appropriateness in these strategies and stresses that adherence to ethical principles is crucial for the effectiveness and compliance of these strategies. The report concludes by referencing relevant literature that supports the importance of ethical practices in healthcare research and interventions.

Running head: ETHICAL CONSIDERATIONS IN HARM REDUCTION STRATEGIES
ETHICAL CONSIDERATIONS IN HARM REDUCTION STRATEGIES
Name of the Student:
Name of the University:
Author note:

1ETHICAL CONSIDERATIONS IN HARM REDUCTION STRATEGIES
Introduction
For the purpose of ensuring complete participant compliance as well as ensuring moral
and ethical compliance with respect to the formulated harm reduction strategies for diabetes
management, the adherence to key ethical considerations is of utmost importance (Tovino 2018).
The following sections will hence briefly expound upon the key ethical considerations to be
addressed with respect to the administration of diabetic harm reduction strategies across
Aboriginals or Indigenous communities.
Discussion
One of first ethical considerations required to be addressed is to acquire ethical approval
for these harm reduction strategies from a relevant review committee. Ethical approvals are
prevalently required for studies or interventions recruiting human subjects and thus, gaining the
same for the assigned harm reduction strategies will ensure their ethical appropriateness.
Likewise, to demonstrate ethical compliance with regards to privacy and autonomy, there is need
to obtain informed consent from Aboriginal clients prior to their participation (Shen et al. 2019).
Additionally, participants must be informed that their participation is voluntary and thus, absence
of the same will not impact the quality of existing acute care interventions given to them. Such
considerations of client privacy will ensure client compliance by instilling positive perceptions in
participations where they will feel that they are being respected and dignified (Arain, Tarraf and
Ahmad 2019). Additionally, the effectiveness of diabetic harm reduction strategies will be
assessed by comparison with participant health data and glucose outcomes. To ensure
confidentiality, such private healthcare data will be securely kept either in locked cabinets or
protected databases with restricted access. Additionally, participant names will be coded or

2ETHICAL CONSIDERATIONS IN HARM REDUCTION STRATEGIES
numbered to protect identity and future prospects of data sharing will be addressed only after
informing participants (Tovino 2018).
Conclusion
Thus, from the above it can be observed that the effectiveness and compliance to the
formulated harm reduction strategies are closely associated with their adherence to ethics.
Additionally, these harm reduction strategies must also be culturally appropriate, the aspects of
which have been discussed in the succeeding sections.

3ETHICAL CONSIDERATIONS IN HARM REDUCTION STRATEGIES
References
Arain, M.A., Tarraf, R. and Ahmad, A., 2019. Assessing staff awareness and effectiveness of
educational training on IT security and privacy in a large healthcare organization. Journal of
multidisciplinary healthcare, 12, p.73.
Shen, N., Sequeira, L., Silver, M.P., Carter-Langford, A., Strauss, J. and Wiljer, D., 2019. Patient
Privacy Perspectives on Health Information Exchange in a Mental Health Context: Qualitative
Study. JMIR mental health, 6(11), p.e13306.
Tovino, S.A., 2018. Remarks on Patient Privacy: Problems, Perspectives, and
Opportunities. Annals Health L., 27, p.243.